Global Hemoglobin A1c Monitoring Market

Hemoglobin A1c Monitoring Comprehensive Study by Type (Ion-exchange, High-performance liquid chromatography (HPLC), Immunoassay, Boronate affinity chromatography, Direct enzymatic assay), Application (HbA1c Laboratory Testing, HbA1c Point of Care Testing) Players and Region - Global Market Outlook to 2030

Hemoglobin A1c Monitoring Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Hemoglobin A1c Monitoring
Hemoglobin A1c test reflects the average amount of glucose for the past two to three months, it is considered to be more reliable than traditional blood glucose tests. Due to the increasing incidence of diabetes and growing awareness of better management of diabetes helping to grow this market. Nowadays, medical professionals usually prescribe HbA1c test over conventional blood glucose tests to patients.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Hemoglobin A1c Monitoring market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Bayer Healthcare Diabetes Care (United States), Abbott Laboratories (United States), Roche Diagnostics (Switzerland), Axis-Shield plc (United Kingdom), Beckman Coulter, Inc. (United States), Bio-Rad Laboratories Inc (United States), Diazyme Laboratories Inc. (United States), EKF Diagnostics Holdings Plc (United Kingdom), HEMOCUE(r) AB (Sweden) and Infopia Co. Ltd. (South Korea) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Menarini Diagnostics Ltd. (United Kingdom), Siemens Healthcare Diagnostics (Germany), Tosoh Bioscience, Inc (United States), Trinity Biotech plc (Ireland) and ARKRAY, Inc. (Japan).

Segmentation Overview
AMA Research has segmented the market of Global Hemoglobin A1c Monitoring market by Type (Ion-exchange, High-performance liquid chromatography (HPLC), Immunoassay, Boronate affinity chromatography and Direct enzymatic assay), Application (HbA1c Laboratory Testing and HbA1c Point of Care Testing) and Region.



On the basis of geography, the market of Hemoglobin A1c Monitoring has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Influencing Trend:
Growing Diabetic Patients Worldwide

Market Growth Drivers:
Growth in Geriatric Population across the Globe and Increasing Healthcare Expenditure

Challenges:
Testing Is Not Always Definitive and Lack of Reimbursement Coverage

Restraints:
High Cost

Opportunities:
The Requirement of HbA1c Testing for Diabetes Diagnosis, Growing Awareness of Better Management of Diabetes and Manufacturers Focus on Offering Products for Developing Markets

Market Leaders and their expansionary development strategies
On May 14, 2019 Abbott has announced that it has partnered with the National Institutes of Health (NIH) on the BRAIN (Brain Research through Advancing Innovative Neurotechnologies) initiative to accelerate advancements in neuroscience research. Abbott will provide the company's neuromodulation technologies.
In May 2022, There is a new and convenient way for millions of individuals to assess whether they are at risk for developing diabetes. Labcorp (NYSE: LH), a leading global life sciences company, is making screening for diabetes easier with the launch of an at-home collection kit through Labcorp OnDemand™ that measures hemoglobin A1c (HbA1c) from a small blood sample.


Key Target Audience
Healthcare Industry, Research Organizations, Governmental Bodies and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Ion-exchange
  • High-performance liquid chromatography (HPLC)
  • Immunoassay
  • Boronate affinity chromatography
  • Direct enzymatic assay
By Application
  • HbA1c Laboratory Testing
  • HbA1c Point of Care Testing
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growth in Geriatric Population across the Globe
      • 3.2.2. Increasing Healthcare Expenditure
    • 3.3. Market Challenges
      • 3.3.1. Testing Is Not Always Definitive
      • 3.3.2. Lack of Reimbursement Coverage
    • 3.4. Market Trends
      • 3.4.1. Growing Diabetic Patients Worldwide
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Hemoglobin A1c Monitoring, by Type, Application and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Hemoglobin A1c Monitoring (Value)
      • 5.2.1. Global Hemoglobin A1c Monitoring by: Type (Value)
        • 5.2.1.1. Ion-exchange
        • 5.2.1.2. High-performance liquid chromatography (HPLC)
        • 5.2.1.3. Immunoassay
        • 5.2.1.4. Boronate affinity chromatography
        • 5.2.1.5. Direct enzymatic assay
      • 5.2.2. Global Hemoglobin A1c Monitoring by: Application (Value)
        • 5.2.2.1. HbA1c Laboratory Testing
        • 5.2.2.2. HbA1c Point of Care Testing
      • 5.2.3. Global Hemoglobin A1c Monitoring Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Hemoglobin A1c Monitoring: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Bayer Healthcare Diabetes Care (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Abbott Laboratories (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Roche Diagnostics (Switzerland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Axis-Shield plc (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Beckman Coulter, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Bio-Rad Laboratories Inc (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Diazyme Laboratories Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. EKF Diagnostics Holdings Plc (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. HEMOCUE(r) AB (Sweden)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Infopia Co. Ltd. (South Korea)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Hemoglobin A1c Monitoring Sale, by Type, Application and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Hemoglobin A1c Monitoring (Value)
      • 7.2.1. Global Hemoglobin A1c Monitoring by: Type (Value)
        • 7.2.1.1. Ion-exchange
        • 7.2.1.2. High-performance liquid chromatography (HPLC)
        • 7.2.1.3. Immunoassay
        • 7.2.1.4. Boronate affinity chromatography
        • 7.2.1.5. Direct enzymatic assay
      • 7.2.2. Global Hemoglobin A1c Monitoring by: Application (Value)
        • 7.2.2.1. HbA1c Laboratory Testing
        • 7.2.2.2. HbA1c Point of Care Testing
      • 7.2.3. Global Hemoglobin A1c Monitoring Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Hemoglobin A1c Monitoring: by Type(USD Million)
  • Table 2. Hemoglobin A1c Monitoring Ion-exchange , by Region USD Million (2018-2023)
  • Table 3. Hemoglobin A1c Monitoring High-performance liquid chromatography (HPLC) , by Region USD Million (2018-2023)
  • Table 4. Hemoglobin A1c Monitoring Immunoassay , by Region USD Million (2018-2023)
  • Table 5. Hemoglobin A1c Monitoring Boronate affinity chromatography , by Region USD Million (2018-2023)
  • Table 6. Hemoglobin A1c Monitoring Direct enzymatic assay , by Region USD Million (2018-2023)
  • Table 7. Hemoglobin A1c Monitoring: by Application(USD Million)
  • Table 8. Hemoglobin A1c Monitoring HbA1c Laboratory Testing , by Region USD Million (2018-2023)
  • Table 9. Hemoglobin A1c Monitoring HbA1c Point of Care Testing , by Region USD Million (2018-2023)
  • Table 10. South America Hemoglobin A1c Monitoring, by Country USD Million (2018-2023)
  • Table 11. South America Hemoglobin A1c Monitoring, by Type USD Million (2018-2023)
  • Table 12. South America Hemoglobin A1c Monitoring, by Application USD Million (2018-2023)
  • Table 13. Brazil Hemoglobin A1c Monitoring, by Type USD Million (2018-2023)
  • Table 14. Brazil Hemoglobin A1c Monitoring, by Application USD Million (2018-2023)
  • Table 15. Argentina Hemoglobin A1c Monitoring, by Type USD Million (2018-2023)
  • Table 16. Argentina Hemoglobin A1c Monitoring, by Application USD Million (2018-2023)
  • Table 17. Rest of South America Hemoglobin A1c Monitoring, by Type USD Million (2018-2023)
  • Table 18. Rest of South America Hemoglobin A1c Monitoring, by Application USD Million (2018-2023)
  • Table 19. Asia Pacific Hemoglobin A1c Monitoring, by Country USD Million (2018-2023)
  • Table 20. Asia Pacific Hemoglobin A1c Monitoring, by Type USD Million (2018-2023)
  • Table 21. Asia Pacific Hemoglobin A1c Monitoring, by Application USD Million (2018-2023)
  • Table 22. China Hemoglobin A1c Monitoring, by Type USD Million (2018-2023)
  • Table 23. China Hemoglobin A1c Monitoring, by Application USD Million (2018-2023)
  • Table 24. Japan Hemoglobin A1c Monitoring, by Type USD Million (2018-2023)
  • Table 25. Japan Hemoglobin A1c Monitoring, by Application USD Million (2018-2023)
  • Table 26. India Hemoglobin A1c Monitoring, by Type USD Million (2018-2023)
  • Table 27. India Hemoglobin A1c Monitoring, by Application USD Million (2018-2023)
  • Table 28. South Korea Hemoglobin A1c Monitoring, by Type USD Million (2018-2023)
  • Table 29. South Korea Hemoglobin A1c Monitoring, by Application USD Million (2018-2023)
  • Table 30. Taiwan Hemoglobin A1c Monitoring, by Type USD Million (2018-2023)
  • Table 31. Taiwan Hemoglobin A1c Monitoring, by Application USD Million (2018-2023)
  • Table 32. Australia Hemoglobin A1c Monitoring, by Type USD Million (2018-2023)
  • Table 33. Australia Hemoglobin A1c Monitoring, by Application USD Million (2018-2023)
  • Table 34. Rest of Asia-Pacific Hemoglobin A1c Monitoring, by Type USD Million (2018-2023)
  • Table 35. Rest of Asia-Pacific Hemoglobin A1c Monitoring, by Application USD Million (2018-2023)
  • Table 36. Europe Hemoglobin A1c Monitoring, by Country USD Million (2018-2023)
  • Table 37. Europe Hemoglobin A1c Monitoring, by Type USD Million (2018-2023)
  • Table 38. Europe Hemoglobin A1c Monitoring, by Application USD Million (2018-2023)
  • Table 39. Germany Hemoglobin A1c Monitoring, by Type USD Million (2018-2023)
  • Table 40. Germany Hemoglobin A1c Monitoring, by Application USD Million (2018-2023)
  • Table 41. France Hemoglobin A1c Monitoring, by Type USD Million (2018-2023)
  • Table 42. France Hemoglobin A1c Monitoring, by Application USD Million (2018-2023)
  • Table 43. Italy Hemoglobin A1c Monitoring, by Type USD Million (2018-2023)
  • Table 44. Italy Hemoglobin A1c Monitoring, by Application USD Million (2018-2023)
  • Table 45. United Kingdom Hemoglobin A1c Monitoring, by Type USD Million (2018-2023)
  • Table 46. United Kingdom Hemoglobin A1c Monitoring, by Application USD Million (2018-2023)
  • Table 47. Netherlands Hemoglobin A1c Monitoring, by Type USD Million (2018-2023)
  • Table 48. Netherlands Hemoglobin A1c Monitoring, by Application USD Million (2018-2023)
  • Table 49. Rest of Europe Hemoglobin A1c Monitoring, by Type USD Million (2018-2023)
  • Table 50. Rest of Europe Hemoglobin A1c Monitoring, by Application USD Million (2018-2023)
  • Table 51. MEA Hemoglobin A1c Monitoring, by Country USD Million (2018-2023)
  • Table 52. MEA Hemoglobin A1c Monitoring, by Type USD Million (2018-2023)
  • Table 53. MEA Hemoglobin A1c Monitoring, by Application USD Million (2018-2023)
  • Table 54. Middle East Hemoglobin A1c Monitoring, by Type USD Million (2018-2023)
  • Table 55. Middle East Hemoglobin A1c Monitoring, by Application USD Million (2018-2023)
  • Table 56. Africa Hemoglobin A1c Monitoring, by Type USD Million (2018-2023)
  • Table 57. Africa Hemoglobin A1c Monitoring, by Application USD Million (2018-2023)
  • Table 58. North America Hemoglobin A1c Monitoring, by Country USD Million (2018-2023)
  • Table 59. North America Hemoglobin A1c Monitoring, by Type USD Million (2018-2023)
  • Table 60. North America Hemoglobin A1c Monitoring, by Application USD Million (2018-2023)
  • Table 61. United States Hemoglobin A1c Monitoring, by Type USD Million (2018-2023)
  • Table 62. United States Hemoglobin A1c Monitoring, by Application USD Million (2018-2023)
  • Table 63. Canada Hemoglobin A1c Monitoring, by Type USD Million (2018-2023)
  • Table 64. Canada Hemoglobin A1c Monitoring, by Application USD Million (2018-2023)
  • Table 65. Mexico Hemoglobin A1c Monitoring, by Type USD Million (2018-2023)
  • Table 66. Mexico Hemoglobin A1c Monitoring, by Application USD Million (2018-2023)
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Hemoglobin A1c Monitoring: by Type(USD Million)
  • Table 78. Hemoglobin A1c Monitoring Ion-exchange , by Region USD Million (2025-2030)
  • Table 79. Hemoglobin A1c Monitoring High-performance liquid chromatography (HPLC) , by Region USD Million (2025-2030)
  • Table 80. Hemoglobin A1c Monitoring Immunoassay , by Region USD Million (2025-2030)
  • Table 81. Hemoglobin A1c Monitoring Boronate affinity chromatography , by Region USD Million (2025-2030)
  • Table 82. Hemoglobin A1c Monitoring Direct enzymatic assay , by Region USD Million (2025-2030)
  • Table 83. Hemoglobin A1c Monitoring: by Application(USD Million)
  • Table 84. Hemoglobin A1c Monitoring HbA1c Laboratory Testing , by Region USD Million (2025-2030)
  • Table 85. Hemoglobin A1c Monitoring HbA1c Point of Care Testing , by Region USD Million (2025-2030)
  • Table 86. South America Hemoglobin A1c Monitoring, by Country USD Million (2025-2030)
  • Table 87. South America Hemoglobin A1c Monitoring, by Type USD Million (2025-2030)
  • Table 88. South America Hemoglobin A1c Monitoring, by Application USD Million (2025-2030)
  • Table 89. Brazil Hemoglobin A1c Monitoring, by Type USD Million (2025-2030)
  • Table 90. Brazil Hemoglobin A1c Monitoring, by Application USD Million (2025-2030)
  • Table 91. Argentina Hemoglobin A1c Monitoring, by Type USD Million (2025-2030)
  • Table 92. Argentina Hemoglobin A1c Monitoring, by Application USD Million (2025-2030)
  • Table 93. Rest of South America Hemoglobin A1c Monitoring, by Type USD Million (2025-2030)
  • Table 94. Rest of South America Hemoglobin A1c Monitoring, by Application USD Million (2025-2030)
  • Table 95. Asia Pacific Hemoglobin A1c Monitoring, by Country USD Million (2025-2030)
  • Table 96. Asia Pacific Hemoglobin A1c Monitoring, by Type USD Million (2025-2030)
  • Table 97. Asia Pacific Hemoglobin A1c Monitoring, by Application USD Million (2025-2030)
  • Table 98. China Hemoglobin A1c Monitoring, by Type USD Million (2025-2030)
  • Table 99. China Hemoglobin A1c Monitoring, by Application USD Million (2025-2030)
  • Table 100. Japan Hemoglobin A1c Monitoring, by Type USD Million (2025-2030)
  • Table 101. Japan Hemoglobin A1c Monitoring, by Application USD Million (2025-2030)
  • Table 102. India Hemoglobin A1c Monitoring, by Type USD Million (2025-2030)
  • Table 103. India Hemoglobin A1c Monitoring, by Application USD Million (2025-2030)
  • Table 104. South Korea Hemoglobin A1c Monitoring, by Type USD Million (2025-2030)
  • Table 105. South Korea Hemoglobin A1c Monitoring, by Application USD Million (2025-2030)
  • Table 106. Taiwan Hemoglobin A1c Monitoring, by Type USD Million (2025-2030)
  • Table 107. Taiwan Hemoglobin A1c Monitoring, by Application USD Million (2025-2030)
  • Table 108. Australia Hemoglobin A1c Monitoring, by Type USD Million (2025-2030)
  • Table 109. Australia Hemoglobin A1c Monitoring, by Application USD Million (2025-2030)
  • Table 110. Rest of Asia-Pacific Hemoglobin A1c Monitoring, by Type USD Million (2025-2030)
  • Table 111. Rest of Asia-Pacific Hemoglobin A1c Monitoring, by Application USD Million (2025-2030)
  • Table 112. Europe Hemoglobin A1c Monitoring, by Country USD Million (2025-2030)
  • Table 113. Europe Hemoglobin A1c Monitoring, by Type USD Million (2025-2030)
  • Table 114. Europe Hemoglobin A1c Monitoring, by Application USD Million (2025-2030)
  • Table 115. Germany Hemoglobin A1c Monitoring, by Type USD Million (2025-2030)
  • Table 116. Germany Hemoglobin A1c Monitoring, by Application USD Million (2025-2030)
  • Table 117. France Hemoglobin A1c Monitoring, by Type USD Million (2025-2030)
  • Table 118. France Hemoglobin A1c Monitoring, by Application USD Million (2025-2030)
  • Table 119. Italy Hemoglobin A1c Monitoring, by Type USD Million (2025-2030)
  • Table 120. Italy Hemoglobin A1c Monitoring, by Application USD Million (2025-2030)
  • Table 121. United Kingdom Hemoglobin A1c Monitoring, by Type USD Million (2025-2030)
  • Table 122. United Kingdom Hemoglobin A1c Monitoring, by Application USD Million (2025-2030)
  • Table 123. Netherlands Hemoglobin A1c Monitoring, by Type USD Million (2025-2030)
  • Table 124. Netherlands Hemoglobin A1c Monitoring, by Application USD Million (2025-2030)
  • Table 125. Rest of Europe Hemoglobin A1c Monitoring, by Type USD Million (2025-2030)
  • Table 126. Rest of Europe Hemoglobin A1c Monitoring, by Application USD Million (2025-2030)
  • Table 127. MEA Hemoglobin A1c Monitoring, by Country USD Million (2025-2030)
  • Table 128. MEA Hemoglobin A1c Monitoring, by Type USD Million (2025-2030)
  • Table 129. MEA Hemoglobin A1c Monitoring, by Application USD Million (2025-2030)
  • Table 130. Middle East Hemoglobin A1c Monitoring, by Type USD Million (2025-2030)
  • Table 131. Middle East Hemoglobin A1c Monitoring, by Application USD Million (2025-2030)
  • Table 132. Africa Hemoglobin A1c Monitoring, by Type USD Million (2025-2030)
  • Table 133. Africa Hemoglobin A1c Monitoring, by Application USD Million (2025-2030)
  • Table 134. North America Hemoglobin A1c Monitoring, by Country USD Million (2025-2030)
  • Table 135. North America Hemoglobin A1c Monitoring, by Type USD Million (2025-2030)
  • Table 136. North America Hemoglobin A1c Monitoring, by Application USD Million (2025-2030)
  • Table 137. United States Hemoglobin A1c Monitoring, by Type USD Million (2025-2030)
  • Table 138. United States Hemoglobin A1c Monitoring, by Application USD Million (2025-2030)
  • Table 139. Canada Hemoglobin A1c Monitoring, by Type USD Million (2025-2030)
  • Table 140. Canada Hemoglobin A1c Monitoring, by Application USD Million (2025-2030)
  • Table 141. Mexico Hemoglobin A1c Monitoring, by Type USD Million (2025-2030)
  • Table 142. Mexico Hemoglobin A1c Monitoring, by Application USD Million (2025-2030)
  • Table 143. Research Programs/Design for This Report
  • Table 144. Key Data Information from Secondary Sources
  • Table 145. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Hemoglobin A1c Monitoring: by Type USD Million (2018-2023)
  • Figure 5. Global Hemoglobin A1c Monitoring: by Application USD Million (2018-2023)
  • Figure 6. South America Hemoglobin A1c Monitoring Share (%), by Country
  • Figure 7. Asia Pacific Hemoglobin A1c Monitoring Share (%), by Country
  • Figure 8. Europe Hemoglobin A1c Monitoring Share (%), by Country
  • Figure 9. MEA Hemoglobin A1c Monitoring Share (%), by Country
  • Figure 10. North America Hemoglobin A1c Monitoring Share (%), by Country
  • Figure 11. Global Hemoglobin A1c Monitoring share by Players 2023 (%)
  • Figure 12. Global Hemoglobin A1c Monitoring share by Players (Top 3) 2023(%)
  • Figure 13. Global Hemoglobin A1c Monitoring share by Players (Top 5) 2023(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Bayer Healthcare Diabetes Care (United States) Revenue, Net Income and Gross profit
  • Figure 16. Bayer Healthcare Diabetes Care (United States) Revenue: by Geography 2023
  • Figure 17. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 18. Abbott Laboratories (United States) Revenue: by Geography 2023
  • Figure 19. Roche Diagnostics (Switzerland) Revenue, Net Income and Gross profit
  • Figure 20. Roche Diagnostics (Switzerland) Revenue: by Geography 2023
  • Figure 21. Axis-Shield plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 22. Axis-Shield plc (United Kingdom) Revenue: by Geography 2023
  • Figure 23. Beckman Coulter, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Beckman Coulter, Inc. (United States) Revenue: by Geography 2023
  • Figure 25. Bio-Rad Laboratories Inc (United States) Revenue, Net Income and Gross profit
  • Figure 26. Bio-Rad Laboratories Inc (United States) Revenue: by Geography 2023
  • Figure 27. Diazyme Laboratories Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Diazyme Laboratories Inc. (United States) Revenue: by Geography 2023
  • Figure 29. EKF Diagnostics Holdings Plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 30. EKF Diagnostics Holdings Plc (United Kingdom) Revenue: by Geography 2023
  • Figure 31. HEMOCUE(r) AB (Sweden) Revenue, Net Income and Gross profit
  • Figure 32. HEMOCUE(r) AB (Sweden) Revenue: by Geography 2023
  • Figure 33. Infopia Co. Ltd. (South Korea) Revenue, Net Income and Gross profit
  • Figure 34. Infopia Co. Ltd. (South Korea) Revenue: by Geography 2023
  • Figure 35. Global Hemoglobin A1c Monitoring: by Type USD Million (2025-2030)
  • Figure 36. Global Hemoglobin A1c Monitoring: by Application USD Million (2025-2030)
  • Figure 37. South America Hemoglobin A1c Monitoring Share (%), by Country
  • Figure 38. Asia Pacific Hemoglobin A1c Monitoring Share (%), by Country
  • Figure 39. Europe Hemoglobin A1c Monitoring Share (%), by Country
  • Figure 40. MEA Hemoglobin A1c Monitoring Share (%), by Country
  • Figure 41. North America Hemoglobin A1c Monitoring Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Bayer Healthcare Diabetes Care (United States)
  • Abbott Laboratories (United States)
  • Roche Diagnostics (Switzerland)
  • Axis-Shield plc (United Kingdom)
  • Beckman Coulter, Inc. (United States)
  • Bio-Rad Laboratories Inc (United States)
  • Diazyme Laboratories Inc. (United States)
  • EKF Diagnostics Holdings Plc (United Kingdom)
  • HEMOCUE(r) AB (Sweden)
  • Infopia Co. Ltd. (South Korea)
Additional players considered in the study are as follows:
Menarini Diagnostics Ltd. (United Kingdom) , Siemens Healthcare Diagnostics (Germany) , Tosoh Bioscience, Inc (United States) , Trinity Biotech plc (Ireland) , ARKRAY, Inc. (Japan)
Select User Access Type

Key Highlights of Report


Mar 2024 248 Pages 94 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Hemoglobin A1c Monitoring Market Quantitative research analysis
Global Hemoglobin A1c Monitoring Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Bayer Healthcare Diabetes Care (United States), Abbott Laboratories (United States), Roche Diagnostics (Switzerland), Axis-Shield plc (United Kingdom), Beckman Coulter, Inc. (United States), Bio-Rad Laboratories Inc (United States), Diazyme Laboratories Inc. (United States), EKF Diagnostics Holdings Plc (United Kingdom), HEMOCUE(r) AB (Sweden) and Infopia Co. Ltd. (South Korea) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Growing Diabetic Patients Worldwide" is seen as one of major influencing trends for Hemoglobin A1c Monitoring Market during projected period 2023-2030.
The Hemoglobin A1c Monitoring market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Hemoglobin A1c Monitoring Market Report?

Have a Query? Click Here

Other Related Reports

Healthcare Provider Population Health Management Platforms Comprehensive Study by End Users (Healthcare Providers, Healthcare Payers, Other), Organization Size (Small and Medium Size Organization, La...
$ 3650
Bed Monitoring System & Baby Monitoring System Comprehensive Study by Type (Baby, Bed), Application (Home Care, Nursing Home & Assisted Living Facilities), End-User (Homecare, Hospitals, Nursing Home...
$ 3800
Cosmetic Procedures Comprehensive Study by Type (Surgical Procedures {Breast Augmentation, Liposuction, Nose Reshaping, Eyelid Surgery, Tummy Tuck, and Facelift}, Non-Surgical Procedures), Applicatio...
$ 3800
Tokenized Securities Comprehensive Study by Type (Equity Token, Debt Token, Real Asset Tokens, Other), Application (STO, ICO) Players and Region - Global Market Outlook to 2027
$ 3500
Medical Rehabilitation Services Comprehensive Study by Type (Preventative Rehabilitation, Restorative Rehabilitation, Supportive Rehabilitation, Palliative Rehabilitation), Application (Hospitals, Ho...
$ 1500
Ticagrelor Comprehensive Study by Application (Acute Coronary Syndromes, Percutaneous Coronary Intervention, Others), Distribution Channel (Retail Pharmacies, Hospitals and Healthcare Facilities, Spe...
$ 3800